India's new Covid cases jump to 2,582 in last 24 hours
In the last 24 hours, the number of Covid tests conducted was 1,51,186 which is also a substantial increase from 92,955 tests conducted in the previous 24 hours (January 1).
In India, 45,769 vaccine doses have been administered in the last 24 hours and the recovery rate currently stands at 98.8 per cent. As of now, the daily positivity rate stands at 0.09 per cent and the weekly positivity rate stands at 0.13 per cent.
According to the Ministry of Health and Family Affairs, total recoveries from Covid stand at 4,41,45,667 with a total 91.12 cr tests having been conducted so far.
COVID-19 vaccination for the age group 12-14 years was started on March 16, 2022. So far, more than 4.12 Cr (4,12,35,971) adolescents have been administered the first dose of the COVID-19 vaccine. Similarly, the COVID-19 precaution dose administration for the age group 18-59 years also started from 10th April 2022 onwards, the official statement read.
It is pertinent to note that health concerns have risen in the country as
XBB, a recombinant lineage between two
Last week, a high-level meeting of Union Health Minister Mansukh Mandaviya with the senior health officials regarding the emergence of Omicron's new sub-variants concluded with the decision to continue masks and COVID-appropriate behaviour across the country.
No second Covid-19 booster dose required: Govt sources
Series creators want more money after ads appear on Netflix
Popular on BI
- A college is removing its vending machines after a student discovered they were using facial-recognition technology
- 11 states pay more in federal taxes than they get back - here's how every state fares
- Steve Jobs once said the best managers are 'individual contributors' who aren't interested in managing people
- Fuel your morning: Wholesome South Indian breakfast ideas for health
- Vodafone Idea shares tumble 14%, mcap erodes ₹10,806.7 cr
- National parties declare income of ₹3,077 cr in 2022-23; BJP has highest share
- Human trials may reveal efficacy of new Rs 100 cancer pill: Docs
- Multiplexes' revenue growth to dip to 15% in FY25 as OTTs crimp profit margins